📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting of low ALK antigen density neuroblastoma using AND logic-gate engineered CAR-T cells. (2023)

First Author: Halliwell E

Attributed to: Phase I study of B7-H3 targeting CAR-T cells administered by local delivery in paediatric high risk brain tumour patients. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jcyt.2022.10.007

PubMed Identifier: 36396552

Publication URI: http://europepmc.org/abstract/MED/36396552

Type: Journal Article/Review

Volume: 25

Parent Publication: Cytotherapy

Issue: 1

ISSN: 1465-3249